Skip to main content
Frontiers in Oncology logoLink to Frontiers in Oncology
. 2023 Nov 20;13:1334056. doi: 10.3389/fonc.2023.1334056

Corrigendum: Epigenetic-mediated downregulation of zinc finger protein 671 (ZNF671) predicts poor prognosis in multiple solid tumors

Jian Zhang 1,2,, Ziqi Zheng 3,, Jieling Zheng 4,, Tao Xie 1,2, Yunhong Tian 1,2, Rong Li 1,2, Baiyao Wang 1,2, Jie Lin 1,2, Anan Xu 1,2, Xiaoting Huang 1,2, Yawei Yuan 1,2,*
PMCID: PMC10694500  PMID: 38053660

In the published article, there was an error in Figure 6 as published. Due to incorrect use of images, we found a minor error in the HOS-ZNF671 (D). We repeated the experiments and corrected the results. The corrected Figure 6 and its caption appear below.

Figure 6.

Figure 6

Effects of ZNF671 overexpression on cell proliferation, migration, and invasion in vitro. (A) Representative Western blot analysis of ZNF671 overexpression in MCF7, Hela, PC9, PANC1, and HOS cell lines. (B) The CCK-8 assay showed overexpression of ZNF671 reduced the viability of MCF7, Hela, PC9, PANC1, and HOS cells. (C, D) Representative images of the effects of ZNF671 overexpression on migratory and invasive abilities of cells as determined by Transwell migration (C) and invasion (D) assays. (E) Quantification of the effects of ZNF671 overexpression on migratory and invasive abilities. All of the experiments were performed at least three times. Data presented are the mean ± SD; **P < 0.01 compared with control using Student’s t-test.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.


Articles from Frontiers in Oncology are provided here courtesy of Frontiers Media SA

RESOURCES